AI assistant
Dr. Lal Pathlabs Limited — Call Transcript 2019
Aug 5, 2019
61783_rns_2019-08-05_c74ae1d9-8068-4292-9b18-813fc3e3c6a8.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [289 x 40] intentionally omitted <==
August 5, 2019
National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla Complex Bandra (E) Mumbai - 400 051.
BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001
Dear Sir/Madam,
Sub: Intimation of Conference Call for Investors/Analysts for Q1 FY 20.
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached the invite of the Conference Call for Investors/Analysts to be held on Tuesday, August 13, 2019 at 4:30 PM 1ST to discuss the financial and operating performance for Q1 FY 20.
You are requested to take note of the above.
Thanking You,
Yours Faithfully,
r. Lal Path Labs ,Lif � fr -., itec. f,c' _I f (�o J \,... ' ,0_ Rajat Kalra '\ Company Secretary and Legal Head
Encl: As above
Regd. Office: Dr. La' Pathi.abs Ltd. i,:, ,ck F Sccror-18. R-.,:,in,, New Dcihi - 110085, -'-91-:: >r2J,.:.no. Fax: +91-l -2788-2134 Corporate Office: Dr. Lal FJthL�t:; Ltd., ! 2�'1 Fi.-.,� _Tower B. SAS Tower. Mi•di, ity, Sectnr-38, G:.:•-.,gram - 122 OC:, Haryana T91. :24-3016-500, Fax: +91-124-4234-46.9 E-mail: la1p�lhlat,,,�•i�Jralhlabs.r,-,rn, Web: ww1,v.Jalpathl�bs c0rn. ClN No.: L7'i;., i9DL 19'i'.;PLC06532-J
'/:,.
Conference Call Invitation
==> picture [209 x 72] intentionally omitted <==
Dr. Lal PathLabs’ Q1 FY20 Concall Invitation
Q1 FY20 Earnings Conference Call Tuesday, August 13, 2019 at 04:30 pm IST
Gurgaon, August 5, 2019:
Dr. Lal PathLabs Ltd. (DLPL) will be hosting a conference call to discuss its Q1 FY20 results. DLPL will be represented by (Hony) Brig. Dr. Arvind Lal - Chairman and Managing Director, Dr. Om Prakash Manchanda - Whole-time Director and CEO, Mr. Ved Prakash Goel - CFO. We would also have Mr. Bharath U - CEO (India Business) and Mr. Rajat Kalra - Company Secretary & Head of Investor Relations.
The conference call will be initiated with a brief discussion by the management on the Q1 FY20 financial and operating performance, which will be announced on the same day. Following this, there will be an opportunity for participants to get their queries addressed during the call.
Details of the conference call are as follows:
| Time | 04:30 pm IST on Tuesday, August 13, 2019 |
|---|---|
| Universal Access | +91 22 6280 1141 +91 22 7115 8042 |
| Local Access | +91-70456 71221 (Available all over India) |
| USA – 18667462133 |
|
| Conference dial-in | UK – 08081011573 |
| International Toll Number | Singapore – 8001012045 |
| Hong Kong – 800964448 |
|
| Replay | +91 22 71945757 / +91 22 66635757 59045 (passcode) Valid from August 13, 2019 to August 19, 2019 |
| Pre-registration | To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial into the call on the Conference Call date and use thepasscode &pin to connect to call |
-ENDS-
Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-I8, Rohini, New Delhi – 110085, Tel: +91-11 30258600. Fax: +91-11-2788-2134 Corporate Office: Or. Lal PathLabs Ltd., 12[th] Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurugram - 122001, Haryana, Tel: +91-124-3016-500, Fax: +91-124-4234-468 E-mail: [email protected], Web: www.lalpathlabs.com, CIN: L74899DL 1995PLC065388
About Dr. Lal PathLabs Limited (DLPL)
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates.
As on March 31, 2019, DLPL’s has 200 clinical labs (including National Reference Lab at Delhi & Regional Reference Lab at Kolkata), 2,569 Patient Service Centers (PSCs) and 6,426 Pick-up Points (PUPs). In FY18 & FY19, DLPL collected and processed approximately 34.7 million samples and 41.8 million samples from approximately 15.2 million and 17.6 million patients, respectively.
Additional information on Dr. Lal PathLabs Limited: Corporate Identification No: L74899DL1995PLC065388 Website: https://www.lalpathlabs.com/
For further information please contact:
Ved Goel / Rajat Kalra Siddharth Rangnekar / Nishid Solanki Dr. Lal PathLabs Limited CDR India Tel: +91 124 301 6500 Tel: +91 22 66451209 / 1221 Fax: +91 124 423 4468 Fax: +91 22 66451213 E-mail:[email protected] Email: [email protected] [email protected] [email protected]
Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-I8, Rohini, New Delhi – 110085, Tel: +91-11 30258600. Fax: +91-11-2788-2134 Corporate Office: Or. Lal PathLabs Ltd., 12[th] Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurugram - 122001, Haryana, Tel: +91-124-3016-500, Fax: +91-124-4234-468 E-mail: [email protected], Web: www.lalpathlabs.com, CIN: L74899DL 1995PLC065388